This put pharma companies in dilemma, if you spend billions but your drug can't bring much profit, the risk vs reward doesn't pay off...it is a good intention, but need to strike a balance.
White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.